The current financial score of GlucoTrack Inc is 6.89. Its financial status is robust, and its operating efficiency is low.
The current valuation score of GlucoTrack Inc is 9.37. Its current P/E ratio is 0.31, which is 109.36% below the recent high of 0.66 and 68539.47% above the recent low of -214.15.
No earnings forecast score is currently available for GlucoTrack Inc. The Biotechnology & Medical Research industry's average is 8.12.
The current price momentum score of GlucoTrack Inc is 6.47. Currently, the stock price is trading between the resistance level at 4.19 and the support level at 0.94, making it suitable for range-bound swing trading.
The current institutional shareholding score of GlucoTrack Inc is 5.00. The latest institutional shareholding proportion is 11.38%, representing a quarter-over-quarter increase of 1400.03%.
The current risk assessment score of GlucoTrack Inc is 1.22. The company's beta value is 0.73. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.